Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

546
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

151
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

SAFETY AND EFFICACY OF INTRAVENOUS COLISTIN IN NEONATES WITH CULTURE PROVEN SEPSIS

Pages

  0-0

Abstract

 Background: Although it is well described among adults, intravenous COLISTIN use and its associated toxicities in newborns are poorly understood.Objectives: We present our experience of efficacy and safety of intravenous COLISTIN in the treatment of SEPSIS in term and preterm NEONATEs.Patients and Methods: The records of NEONATEs who received COLISTIN between January 2013 and February 2014 were retrospectively reviewed. All NEONATEs with culture proven nosocomial INFECTIONs due to multidrug resistant organisms and treated continuously with COLISTIN for more than 72 hours were included in the study.Results: Patients were evaluated for clinical and microbiological response to the drug and its and side effects. Twelve newborn infants with mean 31.8±3.5 weeks gestational age and median 1482 (810 - 3200) gram birth weight were included. 11/12 (91.7%) patients showed microbiological clearance with intravenous COLISTIN. One patient who had recurrent cerebrospinal fluid positive culture was treated with intraventricular COLISTIN. The major side effects observed was hyponatremia and hypokalemia in 2 (16.6%) patients, all infants required magnesium supplementation.Conclusions: Intravenous COLISTIN administration appears to be safe and efficacious for multidrug-resistant gram-negative INFECTIONs in NEONATEs, including PRETERM INFANTs. However, we believe that large prospective controlled studies are needed to confirm its efficacy and safety in NEONATEs.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    SERAFETTIN TEKGUNDUZ, KADIR, KARA, MUSTAFA, CANER, IBRAHIM, & DEMIRELLI, YASAR. (2015). SAFETY AND EFFICACY OF INTRAVENOUS COLISTIN IN NEONATES WITH CULTURE PROVEN SEPSIS. IRANIAN JOURNAL OF PEDIATRICS, 25(4), 0-0. SID. https://sid.ir/paper/664554/en

    Vancouver: Copy

    SERAFETTIN TEKGUNDUZ KADIR, KARA MUSTAFA, CANER IBRAHIM, DEMIRELLI YASAR. SAFETY AND EFFICACY OF INTRAVENOUS COLISTIN IN NEONATES WITH CULTURE PROVEN SEPSIS. IRANIAN JOURNAL OF PEDIATRICS[Internet]. 2015;25(4):0-0. Available from: https://sid.ir/paper/664554/en

    IEEE: Copy

    KADIR SERAFETTIN TEKGUNDUZ, MUSTAFA KARA, IBRAHIM CANER, and YASAR DEMIRELLI, “SAFETY AND EFFICACY OF INTRAVENOUS COLISTIN IN NEONATES WITH CULTURE PROVEN SEPSIS,” IRANIAN JOURNAL OF PEDIATRICS, vol. 25, no. 4, pp. 0–0, 2015, [Online]. Available: https://sid.ir/paper/664554/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top